endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies
Rhinology Journal · 2025
DOI: 10.4193/rhin25.291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhinology Journal, 2025. Verfasst von M Xian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Rhinitis, Sinusitis, Biological Products, Nasal Polyps.
Abstract (Originalsprache)
We read with great interest the recent study by Fieux et al. (1), which developed an evaluation model based on clinical practices, public health insurance, and private insurance systems in France. Through rigorous cost-effectiveness analysis, the authors concluded that initiating biologic therapy in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) without previous endoscopic sinus surgery (ESS) imposes excessive economic burdens. This finding aligns with the current guideline regarding the indications for biological treatment in CRSwNP, which reserves biologics primarily for patients with prior ESS history.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
- Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China;Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Zitieren
APA
Xian, M., Wang, C., & Zhang, L. (2025). endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies. Rhinology Journal. https://doi.org/10.4193/rhin25.291
Vancouver
Xian M, Wang C, Zhang L. endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies. Rhinology Journal. 2025. doi:10.4193/rhin25.291
BibTeX
@article{Xian2025,
author = {Xian, M and Wang, C and Zhang, L},
title = {endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies},
journal = {Rhinology Journal},
year = {2025},
doi = {10.4193/rhin25.291}
}
EUVIMED